The first graph shows the progression from Receipt of I.D.E to First patient enrollment.
The second diagram shows how the E.F.S study will transition to the Pivotal I.D.E study, then onto the P.M.A. submission for full device market approval.
We still have more hoops to jump through but heading in the right direction!
Good times ahead
The first graph shows the progression from Receipt of I.D.E to...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |